{"date":"2025-05-06","count":36,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6885-2025-05-06-2047-16jgf2c","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2025-05-06","time":"20:47:45","subject":"公告本公司董事會決議通過114年度第一季財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2025-05-06 20:47，「公告本公司董事會決議通過114年度第一季財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2025-05-06-1926-1wpawso","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2025-05-06","time":"19:26:12","subject":"公告本公司現金增資認股基準日等相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2025-05-06 19:26，「公告本公司現金增資認股基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2025-05-06-1924-1ctd1xg","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2025-05-06","time":"19:24:48","subject":"公告本公司董事會通過與海思科醫藥集團簽訂SYN010產品補充協議案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2025-05-06 19:24，「公告本公司董事會通過與海思科醫藥集團簽訂SYN010產品補充協議案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2025-05-06-1924-oi9rmi","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2025-05-06","time":"19:24:28","subject":"本公司董事會決議收回已發行之限制員工權利新股註銷減資事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2025-05-06 19:24，「本公司董事會決議收回已發行之限制員工權利新股註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2025-05-06-1924-qvvd1p","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2025-05-06","time":"19:24:08","subject":"公告本公司董事會通過114年第1季財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2025-05-06 19:24，「公告本公司董事會通過114年第1季財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2025-05-06-1922-1s7xzm3","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2025-05-06","time":"19:22:03","subject":"公告本公司向關係人取得使用權資產","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2025-05-06 19:22，「公告本公司向關係人取得使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2025-05-06-1921-1nabwkf","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2025-05-06","time":"19:21:44","subject":"本公司董事會決議通與Almac Discovery之授權協議，將引進ALM-401首個以治療實體腫瘤為目標的EGFR/ROR1標靶雙特異性抗體藥物複合體","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2025-05-06 19:21，「本公司董事會決議通與Almac Discovery之授權協議，將引進ALM-401首個以治療實體腫瘤為目標的EGFR/R」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2025-05-06-1921-9qofud","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2025-05-06","time":"19:21:22","subject":"公告本公司董事會通過114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2025-05-06 19:21，「公告本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2025-05-06-1835-1y6nzqn","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2025-05-06","time":"18:35:27","subject":"公告本公司114年第一季合併財務報告董事會預計召開日期為114年5月14日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2025-05-06 18:35，「公告本公司114年第一季合併財務報告董事會預計召開日期為114年5月14日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2025-05-06-1810-xo2pc7","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2025-05-06","time":"18:10:02","subject":"公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2025-05-06 18:10，「公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2025-05-06-1809-1oq17s0","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2025-05-06","time":"18:09:22","subject":"公告本公司董事會通過114年第1季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2025-05-06 18:09，「公告本公司董事會通過114年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2025-05-06-1808-1hrnkds","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2025-05-06","time":"18:08:43","subject":"代子公司科進製藥科技股份有限公司公告董事會通過113年度現金股利基準日及發放日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2025-05-06 18:08，「代子公司科進製藥科技股份有限公司公告董事會通過113年度現金股利基準日及發放日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2025-05-06-1808-qtbhqi","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2025-05-06","time":"18:08:09","subject":"代子公司科進製藥科技股份有限公司公告114年第1季財務報表提報董事會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2025-05-06 18:08，「代子公司科進製藥科技股份有限公司公告114年第1季財務報表提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2025-05-06-1758-1j4y0mq","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2025-05-06","time":"17:58:07","subject":"(7724)諾亞克-更正113年度合併財報P.52數字誤植","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2025-05-06 17:58，「(7724)諾亞克-更正113年度合併財報P.52數字誤植」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6483-2025-05-06-1721-1hwynq2","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-06","time":"17:21:06","subject":"公告本公司與S公司簽訂開發緩釋型維他命C+E產品合約","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2025-05-06 17:21，「公告本公司與S公司簽訂開發緩釋型維他命C+E產品合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6850-2025-05-06-1719-1vdbhy4","company_id":"6850","company":"光鼎生技","market":"興櫃","industry":"生技醫療","date":"2025-05-06","time":"17:19:40","subject":"公告本公司與某國際生技儀器公司簽訂貼牌合作協議","clause":"第8款","fact_date":"2025-05-06","cite_as":"公開資訊觀測站重大訊息：光鼎生技（6850），2025-05-06 17:19，「公告本公司與某國際生技儀器公司簽訂貼牌合作協議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2025-05-06-1717-qkw3o","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2025-05-06","time":"17:17:59","subject":"公告本公司114年第一季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2025-05-06","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2025-05-06 17:17，「公告本公司114年第一季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2025-05-06-1714-mryhxc","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2025-05-06","time":"17:14:05","subject":"本公司受邀參加兆豐證券所舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2025-05-06 17:14，「本公司受邀參加兆豐證券所舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2025-05-06-1704-m32c8p","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2025-05-06","time":"17:04:38","subject":"公告本公司竹北廠廠房新建工程追加工程款","clause":"第17款","fact_date":"2025-05-06","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2025-05-06 17:04，「公告本公司竹北廠廠房新建工程追加工程款」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2025-05-06-1704-1afkhuq","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2025-05-06","time":"17:04:06","subject":"公告本公司董事會決議召開114年股東常會相關事宜（議案增修）","clause":"第32款","fact_date":"2025-05-06","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2025-05-06 17:04，「公告本公司董事會決議召開114年股東常會相關事宜（議案增修）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2025-05-06-1613-qvvd1p","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2025-05-06","time":"16:13:42","subject":"公告本公司董事會通過114年第1季財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2025-05-06 16:13，「公告本公司董事會通過114年第1季財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6649-2025-05-06-1606-1urxqie","company_id":"6649","company":"台生材","market":"上櫃","industry":"生技醫療","date":"2025-05-06","time":"16:06:21","subject":"公告本公司董事會通過114年第一季財務報告","clause":"第31款","fact_date":"2025-05-06","cite_as":"公開資訊觀測站重大訊息：台生材（6649），2025-05-06 16:06，「公告本公司董事會通過114年第一季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-05-06-1605-qkw3o","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-05-06","time":"16:05:36","subject":"公告本公司114年第一季合併財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-05-06 16:05，「公告本公司114年第一季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2025-05-06-1559-wsqazv","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2025-05-06","time":"15:59:00","subject":"公告本公司董事會決議通過114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2025-05-06 15:59，「公告本公司董事會決議通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2025-05-06-1530-1jda4d","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2025-05-06","time":"15:30:13","subject":"公告本公司114年第1季財務報告董事會預計召開日期為114年05月14日","clause":"第31款","fact_date":"2025-05-06","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2025-05-06 15:30，「公告本公司114年第1季財務報告董事會預計召開日期為114年05月14日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2025-05-06-1514-13rpxz5","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2025-05-06","time":"15:14:56","subject":"公告本公司訂定除息基準日等相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2025-05-06 15:14，「公告本公司訂定除息基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2025-05-06-1514-1hqsogb","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2025-05-06","time":"15:14:27","subject":"公告本公司調整配息率","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2025-05-06 15:14，「公告本公司調整配息率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-05-06-1510-1084d2y","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-05-06","time":"15:10:34","subject":"公告本公司董事會決議設置永續發展委員會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-05-06 15:10，「公告本公司董事會決議設置永續發展委員會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-05-06-1510-5rax5d","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-05-06","time":"15:10:24","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-05-06 15:10，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-05-06-1510-34098y","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-05-06","time":"15:10:10","subject":"公告本公司董事會通過114年第一季個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-05-06 15:10，「公告本公司董事會通過114年第一季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-05-06-1509-1aoweer","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-05-06","time":"15:09:40","subject":"公告本公司董事會通過公司治理主管任命案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-05-06 15:09，「公告本公司董事會通過公司治理主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-05-06-1431-vq48pm","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-05-06","time":"14:31:11","subject":"代重要子公司潤雅生技股份有限公司公告董事會決議113年度不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-05-06 14:31，「代重要子公司潤雅生技股份有限公司公告董事會決議113年度不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-05-06-1430-tee9ve","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-05-06","time":"14:30:26","subject":"代重要子公司潤雅生技股份有限公司公告董事會決議召開114年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-05-06 14:30，「代重要子公司潤雅生技股份有限公司公告董事會決議召開114年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2025-05-06-1420-9qofud","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2025-05-06","time":"14:20:14","subject":"公告本公司董事會通過114年第一季合併財務報告","clause":"第31款","fact_date":"2025-05-06","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2025-05-06 14:20，「公告本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2025-05-06-1400-9qofud","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2025-05-06","time":"14:00:16","subject":"公告本公司董事會通過114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2025-05-06 14:00，「公告本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2025-05-06-1354-1ysqeq2","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2025-05-06","time":"13:54:40","subject":"公告本公司因會計師事務所內部職務輪調更換會計師","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2025-05-06 13:54，「公告本公司因會計師事務所內部職務輪調更換會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}